4//SEC Filing
Kollins John A 4
Accession 0001567619-22-012477
CIK 0001692830other
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 5:38 PM ET
Size
5.6 KB
Accession
0001567619-22-012477
Insider Transaction Report
Form 4
Kollins John A
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2022-06-03+505,000→ 505,000 totalExercise: $3.46Exp: 2032-06-02→ Common Stock (505,000 underlying)
Footnotes (1)
- [F1]Twenty Five Percent (25%) of the shares subject to the option vest one year measured from June 3, 2022 and the remaining shares subject to the option vest in 36 successive, equal monthly installments thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
Documents
Issuer
Satsuma Pharmaceuticals, Inc.
CIK 0001692830
Entity typeother
Related Parties
1- filerCIK 0001391070
Filing Metadata
- Form type
- 4
- Filed
- Jun 6, 8:00 PM ET
- Accepted
- Jun 7, 5:38 PM ET
- Size
- 5.6 KB